AyuSynk

Adarsh Kachappilly (CEO) is from Karnataka and drives the company's commercial strategy and growth. His background in healthcare technology entrepreneurship and his exposure to IIT's innovation ecosystem gave him the domain understanding to identify that the stethoscope the most universally recognised medical device had not received a meaningful technological upgrade in 200 years. Tapas Pandey (Head of Hardware) brings the electronic engineering capability to build the signal processing and amplification hardware that transforms an analogue stethoscope into a digital data-capturing device. Varad Patil (Head of Software) built the AyuSynk application that provides visual representation of heart and lung sounds, enabling live streaming, WhatsApp sharing, and diagnostic recording.

The first indigenous digital stethoscope produced in India by AyuDevices can detect heart murmurs and pulmonary problems thanks to its 16-fold amplification of heart and lung sounds. The Digital Stethoscope name is AyuSynk. Through medical innovation, they have tried to reduce the incidence of heart and lung issues being misdiagnosed, particularly in rural areas. The stethoscope can both capture and distribute heart sounds via WhatsApp. It is instrumental in the medical area, where many instances of misdiagnosis and congenital heart diseases result in early diagnosis and the death of many children.

Amount Asked: ₹1 crore Equity Offered: 1.5% Implied Pre-Money Valuation: ₹66.67 crore

The pitch opened with the "200-year pending upgrade" framing: Since 200 years, technology has grown rapidly, but the stethoscope still lies in its place. So that is why they have brought the 200 years pending upgrade with the AyuSynk. The product demonstration involved inviting Peyush Bansal to listen through the AyuSynk-enhanced stethoscope, experiencing the 16x amplification and noise removal firsthand. The Sharks could hear the difference between a conventional stethoscope and AyuSynk's enhanced audio in real time. The founders then demonstrated the app: showing how heart sounds were simultaneously visualised as waveforms on a connected phone screen while being recorded, and how a doctor in Mumbai could receive those sounds streamed live from a health worker in a village. The tele-auscultation demonstration was the most direct and most compelling illustration of the device's rural healthcare impact potential.

Vineeta Singh exited citing lack of specialisation in the healthcare technology space. Aman Gupta exited with specific pricing concerns. Aman had concerns about the selling price of the product. Anupam Mittal exited with the most commercially cautious assessment. Anupam thinks this is a solution looking for a problem, and he does not think the market is huge. Peyush Bansal made the first formal offer. He offered ₹50 lakhs for 5% equity plus ₹50 lakhs in debt at 12% interest. Namita Thapar declined to share the deal and delivered one of Season 2's most memorable Shark moments. She proclaimed her transformation from "a dolphin to a shark" and insisted on going solo.

Peyush offered ₹50 lakhs for 5% equity plus ₹50 lakhs debt at 12% interest. Namita countered with a solo offer of ₹50 lakhs for 4% equity plus ₹50 lakhs debt at 10% interest. The team countered at 3.5% equity for the same capital structure. Namita accepted the 3.5% equity counteroffer. The deal was finalised at ₹50 lakhs for 3.5% equity plus ₹50 lakhs debt at 10% interest, with Namita investing solo.

Adarsh Kachappilly, Tapas Pandey, and Varad Patil accepted Namita Thapar's solo offer of ₹50 lakhs for 3.5% equity plus ₹50 lakhs debt at 10% interest, valuing AyuSynk at ₹14.29 crore post-deal. The deal did not formally close after the episode aired, though AyuSynk continues to operate with over 6,000 users and three digital stethoscope product variants.